Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy

Detalles Bibliográficos
Autores principales: Prithviraj, Prashanth, McArthur, Grant, Atkinson, Victoria, Parente, Phillip, Andrews, Miles, Parakh, Sagun, Millward, Michael, Cebon, Jonathan, Klein, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645483/
http://dx.doi.org/10.1186/2051-1426-3-S2-P126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645483/
http://dx.doi.org/10.1186/2051-1426-3-S2-P126

Ejemplares similares